'20,000 doses of meningitis C vaccine recalled over contamination threat'

The doses had been sent out “about a week ago” to GP clinics around the country.

Why are the vaccine doses being recalled?

Sterility tests carried out by the pharmaceutical company that makes the vaccine Menjugate found that two batches had been contaminated with the bacterium Staphylococcus aureus. Although these two batches had not been distributed to the UK, the company decided to recall other batches that had been sent to the UK as a precaution. It says there is no evidence at present that the batches distributed in the UK are affected.

If there is no problem why have these batches of vaccine been withdrawn?

The company says that this is an entirely precautionary measure and there is no reason to believe the UK batches are a risk. They have been withdrawn to “ensure that there are no grounds for anyone to be concerned”. It said the Medicines and Healthcare products Regulatory Agency (MHRA) has no reports of adverse reactions associated with these batches.

Are UK children at risk?

The company says, “there is no reason for UK children to be at any risk from this product”, and that all vaccine sent to the UK had passed the required tests.

What action should be taken if a child has recently had this vaccine?

Other meningitis vaccines and other batches of Menjugate are not affected by the recall. If a parent has any concerns about the vaccine administered to their child they should discuss this with their doctor.

This article was originally published by NHS Choices

Have your say

You must sign in to make a comment.